Parallax Volatility Advisers, L.P. Vericel Corp Transaction History

Parallax Volatility Advisers, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$30.93 - $59.48 $18,774 - $36,104	-607 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$30.93 - $59.48 $18,774 - $36,104	607 New	607 $34,000
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $87,058 - $109,562	-5,800 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $17,853 - $22,319	1,100 Added 23.4%	5,800 $102,000
Q4 2018 Feb 14, 2019	BUY	$10.77 - $18.44 $49,918 - $85,469	4,635 Added 7130.77%	4,700 $82,000
Q3 2018 Nov 14, 2018	SELL	$9.1 - $14.8 $17,726 - $28,830	-1,948 Reduced 96.77%	65 $1,000
Q4 2017 Feb 14, 2018	SELL	$3.65 - $5.98 $4,015 - $6,578	-1,100 Reduced 35.34%	2,013 $11,000
Q3 2017 Nov 14, 2017	BUY	$3.0 - $6.0 $9,339 - $18,678	3,113	3,113 $19,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.48B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.